Skip to content
Mojia Biotech logo — Green Solutions for a Better World

Mojia Biotech

Green Solutions for a Better World

Founded 2018 Singapore Singapore 16 employees Series B Total: $237.70M Agriculture, Biotechnology

General Information

Company Name Mojia Biotech
Founded Year 2018
Location Singapore Singapore
Employees 16
Industries Agriculture, Biotechnology
Funding Stage Series B
Business Model B2B, B2B2B, White Label
Revenue Model Product Sales, Service Fee, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Mojia Biotech. To contact Mojia Biotech, visit mojia.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Mojia Biotech compare?

A PDF of Mojia Biotech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Mojia Biotech soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Mojia Biotech

Mojia Biotech Analysis

Mojia Bio is a rapidly growing biomanufacturing company with a strong focus on sustainability and contributing to a circular bioeconomy. Founded in 2018, the company is dedicated to developing and implementing sustainable chemical manufacturing technologies using renewable carbon sources and green processes. Its diverse product portfolio includes food ingredients and a variety of bio-based materials.

Operating out of Singapore, with research and development activities spanning China, Singapore, and the US, Mojia Bio also boasts manufacturing sites in China. The recent $80.00M Series B investment on 22 June 2022 indicates substantial support from notable investors including Bits x Bites, Temasek Holdings, Asia Green Fund, LYZZ CAPITAL, and Sento Investment.

Mojia Bio's commitment to green solutions and sustainability, as well as its strong investor backing, positions the company as a promising player in the agriculture and biotechnology industries, poised for significant impact on a global scale.

Business keywords: biomanufacturing, circular bioeconomy, renewable carbon sources, green processes, food ingredients, bio-based materials, chemical manufacturing technologies, Singapore headquarters, R&D activities, manufacturing sites, fast-growing company

Services & Products

Biomanufacturing Solutions
Industrial Production Facilities
Research and Development in Biotechnology
Partnership Development

Target Customers

Industrial Partners Environmental Organizations Supply Chain Companies Agricultural Sector Stakeholders

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $80.00M 5
Bits x Bites, Temasek Holdings +3
22 Jun 2022
Series A $120.00M 3
Bits x Bites, U.S.-China Green Fund +1
30 Sep 2021
Series A $37.70M 2
Bits x Bites, Asia Green Fund
14 Dec 2020

Mojia Biotech Alternatives & Competitors

View All Alternatives
Mojia Biotech vs

Pioneering sustainable solutions for natural rubber and fuel ethanol feedstock production.

Seed
2-10 employees
Agriculture, Biotechnology
Mojia Biotech vs

Humic Substances Based Biostimulants. Made in Germany. Successful all over the world.

30 employees
Agriculture, Biotechnology
Mojia Biotech vs
EntoPro SAS
EntoPro SAS Colombia

Insectos y economía circular

8 employees
Agriculture, Biotechnology

FAQ About Mojia Biotech

Green Solutions for a Better World
Mojia Biotech was founded in 2018.
Mojia Biotech is headquartered in Singapore.
Mojia Biotech operates in Agriculture and Biotechnology. Its work centres on biomanufacturing, circular bioeconomy, renewable carbon sources and green processes. Its customers include Industrial Partners, Environmental Organizations and Supply Chain Companies.
Mojia Biotech has a B2B, B2B2B and White Label business model. Its revenue comes from Product Sales, Service Fee and Licensing.
Mojia Biotech has approximately 16 employees.
Mojia Biotech has completed 3 funding rounds, raising a total of $237.70M. The latest funding stage is Series B.
Mojia Biotech offers: Biomanufacturing Solutions, Industrial Production Facilities, Research and Development in Biotechnology, Partnership Development.
Top alternatives and competitors to Mojia Biotech include Delta Plant Technologies, HUMINTECH GmbH, EntoPro SAS, ChainCraft, AgraQuest. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mojia Biotech and Delta Plant Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Mojia Biotech, https://bouncewatch.com/company/mojia-biotech, updated 29 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout